The Composition of Cigarette Smoke: Problems with Lists of Tumorigens

Open access

Abstract

Since the mid-1960s, various investigators, agencies, and institutions have disseminated lists of cigarette mainstream smoke (MSS) components reported to be tumorigenic on the basis of laboratory bioassays conducted under conditions significantly different from those encountered by the smoker during exposure to the components in the cigarette MSS aerosol. Since 1990, numerous lists of cigarette MSS components, defined as significant tumorigens, have been compiled by American Health Foundation personnel, Occupational Safety and Health Administration (OSHA), Fowles and Bates, and R.J. Reynolds R&D personnel. The purpose of most of the reports was to define human risk assessment and to dissuade smokers from smoking. Various investigators and agencies have frequently cited the earlier and/or the more recent lists of tumorigenic entities. The recent compilations, involving nearly 80 MSS components, suffer from serious deficiencies including: a) Use of per cigarette delivery ranges for specified components which often include analytical data from cigarettes manufactured in the 1950s and 1960s which are not comparable to lower-'tar’ yield cigarettes manufactured since the mid-1970s. b) Absence of standard analytical procedures for most of the listed components. c) Methodological considerations regarding bioassays used to determine tumorigenicity of the listed MSS components. d) Difficulty in extrapolating in vivo bioassay data obtained by non-inhalation modes of administration of a single compound to the human smoking situation involving inhalation of a complex aerosol containing that compound. e) Inhalation data inadequacies regarding the tumorigenicity of many of the components. f) Several tobacco smoke components are listed despite the fact their presence has not been confirmed, their MSS level has not been defined, or their MSS level is no longer relevant. g) Insufficient consideration of inhibitors of tumorigenesis and mutagenesis found in MSS. h) Difficulty in extrapolation of inhibition/anticarcinogenesis/antimutagenesis observed in a one-on-one in vivo situation to the complex MSS aerosol situation. j) Alternate exposures to many of the listed smoke components. k) Discrepancies among the lists. l) Discrepancies within the lists.A more appropriate use of the listing process is the identification of potential chemical targets for removal from, or inhibition in cigarette MSS.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Rodgman A.: The N-nitrosamines in tobacco and tobacco smoke; October 1993: pp. i-xv 1–259: see www.rjrtdocs.com 509752851 -3134

  • 2. Hoffmann D. and E.L. Wynder: Chemical constitu-ents and bioactivity of tobacco smoke; in: Tobacco: A major health hazard edited by D.G. Zardidze and R. Peto IARC Lyon France IARC Sci. Publ. No. 74 (1986) 145–165.

  • 3. IARC: Chemistry and analysis of tobacco smoke; in: Evaluation of the carcinogenic risk of chemicals to humans: Tobacco smoking; IARC Lyon France IARC Monograph 38 1986 pp. 83–126 387–394.

  • 4. Hoffmann D. and S.S. Hecht: Advances in tobacco carcinogenesis; in: Chemical carcinogenesis and muta-genesis. I edited by C.S. Cooper and P. Grover Springer-Verlag London U.K. 1990 Chapter 3 pp. 63–102.

  • 5. Hoffmann D. A. Rivenson F.L. Chung and E.L. Wynder: Potential inhibitors of tobacco carcinogene-sis; in: Tobacco smoking and nutrition: Influence of nutrition on tobacco-associated health risks edited by J.N. Diana and W.A. Prior Ann. N.Y. Acad. Sci. 686 (1993) 140–160.

  • 6. Wynder E.L. and D. Hoffmann: Tobacco and tobacco smoke: Studies in experimental carcinogenesis; Academic Press New York N.Y. 1967 pp. 496–501.

  • 7. Wynder E.L. and D. Hoffmann: Tobacco and health: A societal challenge; New Eng. J. Med. 300 (1979) 894–903.

  • 8. Wynder E.L. and D. Hoffmann: Tobacco; in: Cancer epidemiology and prevention edited by D. Schotten-feld and J.F. Frauneni Jr W.B. Saunders Philadelphia PA 1982 pp. 277–292.

  • 9. Closing Quotes Department: Dietrich Hoffmann: Author of the list; Tobacco Reporter (July 2002) pp. 70–72.

  • 10. Occupational Safety and Health Administration: Indoor air quality; Fed. Reg. 59 (No. 65) (1994) 15968–16039.

  • 11. Hoffmann D. and I. Hoffmann: The changing ciga-rette: 1950–1995; J. Toxicol. Environ. Hlth. 50 (1997) 307–364.

  • 12. Hoffmann D. and I. Hoffmann: Tobacco smoke components. Letter to the Editor; Beitr. Tabakforsch. Int. 18 (1998) 49–52.

  • 13. Smith C.J. S.D. Livingston and D.J. Doolittle: An international literature survey of “IARC Group 1 carcinogens” reported in mainstream smoke; Food Chem. Toxicol. 35 (1997) 1107–1130; Smith C.J. T.A. Perfetti M.A. Mullens A. Rodgman and D.J. Doolittle: An international literature survey of IARC carcinogens in cigarette mainstream smoke; 53rd Tobacco Science Research Conference Program Booklet and Abstracts Vol. 53 Paper No. 28 1999 pp. 34–35.

  • 14. Smith C.J. T.A. Perfetti M.A. Rumple A. Rodgman and D.J. Doolittle: “IARC Group 2A carcinogens” reported in cigarette mainstream smoke; Food Chem. Toxicol. 38 (2000) 371–383.

  • 15. Smith C.J. T.A. Perfetti M.A. Rumple A. Rodgman and D.J. Doolittle: “IARC Group 2B carcinogens” reported in cigarette mainstream smoke; Food Chem. Toxicol. 39 (2001) 183–205.

  • 16. Hoffmann D. and I. Hoffmann: The changing ciga-rette: Chemical studies and bioassays; in: Risks associated with cigarettes with low machine-measured yields of tar and nicotine NCI smoking and tobacco control Monograph 13 edited by D.M. Burns and N.L. Benowitz United States Department of Health and Human Services Bethesda MD Chapter 5 (2001) 159–191.

  • 17. Hoffmann D. I. Hoffmann and K. El-Bayoumy: The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder; Chem. Res. Toxicol. 14 (2001) 767–790.

  • 18. Fowles J. and M. Bates: The chemical constituents in cigarettes and cigarette smoke: Priorities for harm reduction. A Report to the New Zealand Ministry of Health March 2000 pp. 1–65.

  • 19. Rodgman A. and C.R. Green: Toxic chemicals in cigarette mainstream smoke – hazard and hoopla; in: Cigarette risk and the potential for risk reduction Invited Speaker Symposium Proceedings 2002 CORESTA Congress New Orleans LA pp. 2–52.

  • 20. Wynder E.L. and D. Hoffmann: Experimental tobacco carcinogenesis; Science 162 (1968) 862–871.

  • 21. Van Duuren B.L. J.A. Bilbao and C.A. Joseph: The origin and nature of the nitrogen heterocyclics in cigarette smoke condensate; Proc. Am. Chem. Soc. Mtg.-in-Miniature New York N.Y. 1960; The carcinogenic nitrogen heterocycles in cigarette smoke condensate; J. Natl. Cancer Inst. 25 (1950) 53–61.

  • 22. United States Public Health Service: Smoking and health. Report of the Advisory Committee to the Surgeon General of the Public Health Service; DHEW Publ. No. (PHS) 1103 1964.

  • 23. Hoffmann D. and E.L. Wynder: Selective reduction of the tumorigenicity of tobacco smoke. Experimental approaches; in: Toward a less harmful cigarette Proceedings of Workshop on Smoking and Health September 1967 edited by E.L. Wynder and D. Hoffmann Natl. Cancer Inst. Monograph 28 Washington D.C. 1968 pp. 151–172.

  • 24. United States Public Health Service: Smoking and health. A report of the Surgeon General; DHEW Publ. No. (PHS) 79-50066 1979.

  • 25. United States Public Health Service: The health consequences of smoking. The changing cigarette. A report of the Surgeon General; DHHS Publ. No. (PHS) 81-50156 1981.

  • 26. United States Public Health Service: The health conse-quences of smoking. Cancer. A report of the Surgeon General; DHHS Publ. No. (PHS) 82-50179 1982.

  • 27. United States Public Health Service: The health consequences of involuntary smoking. A report of the Surgeon General 1986; DHHS Publ. No. (PHS) 87-8398 1987.

  • 28. Editors: Seminars in tobacco science: Tobacco smoke components; Beitr. Tabakforsch. Int. 17 (1997) 61–66: see Table 6.

  • 29. Rodgman A.: Tobacco smoke components. Letter to the Editor; Beitr. Tabakforsch. Int. 18 (1998) 127–129.

  • 30. Kamata K. N. Motohashi R. Meyer and Y. Yama-moto: Analysis of benz[c]acridines in cigarette smoke by high-performance liquid chromatography; J. Liq. Chromatog. 15 (1992) 1907–1920.

  • 31. Sasaki T.A. and S.C. Moldoveanu: Analysis of dibenz[aj]acridine in particulate-phase cigarette smoke; 53rd Tobacco Science Research Conference Program Booklet and Abstracts Vol. 53 Paper No. 32 1999 p. 37; Determination of dibenz[aj]acridine in the particulate phase of cigarette smoke; Beitr. Tabakforsch. Int. 19 (2000) 25–31.

  • 32. Baker R.R: Smoke chemistry; in: Tobacco: Production chemistry and technology edited by D.L. Davis and M.T. Nielsen Blackwell Science Oxford U.K. 1999 pp. 398–439: see pp. 423–424 and Table 12-7.

  • 33. Rodgman A. C.J. Smith and T.A. Perfetti: The composition of cigarette smoke: A retrospective with emphasis on polycyclic compounds; Human Exptl. Tox. 19 (2000) 573–595.

  • 34. Rustemeier K. R. Stabbert H.J. Haussmann E. Roemer and E.L. Carrnines: Evaluation of the poten-tial effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke: Food Chem. Toxicol. 40 (2002) 93–104.

  • 35. Environmental Protection Agency: Health effects of passive smoking: assessment of lung cancer in adults and respiratory disorders in children; Draft Document EPA/600/6-90/006A (May 1990);. Environmental tobacco smoke: A guide to workplace smoking poli-cies. Draft Document EPA/400/6-90/004 (June 25 1990).

  • 36. Environmental Protection Agency: Respiratory health effects of passive smoking: lung cancer and other disorders; Draft Document EPA/600/6-90/006B (May 1992).

  • 37. Rodgman A.: A comparison of the chemical and physical properties of cigarette mainstream smoke (MS) cigarette sidestream smoke (SS) and environ-mental tobacco smoke (ETS). Document submitted to the Environmental Protection Agency December 1991. Revised version submitted June 1992 pp. vii + 117 www.rjrtdocs.com 510649075-9111; 508137542 -7573.

  • 38. Rodgman A.: The chemical composition of environ-mental tobacco smoke: Some comments on the Occu-pational Safety and Health Administration's notice on ‘Indoor air quality;’ Document submitted to Occupational Safety and Health Administration 5 August 1994 pp. xiii + 172: see www.rjrtdocs.com 515923456 -3645; 515926645 -6833.

  • 39. Rodgman A.: Environmental tobacco smoke; Regul. Toxicol. Pharmacol. 16 (1992) 223–244.

  • 40. IARC: Tobacco habits other than smoking: Betel-quid and areca-nut chewing and some related nitrosamines; IARC Lyon France IARC Monograph 37 1985.

  • 41. United States Public Health Service: Reducing the health consequences of smoking 25 years of progress. A report of the Surgeon General; DHHS Publ. No. (CDC) 89-8411 1989: see pp. 82–85.

  • 42. Harley N.H. B.S. Cohen and T.C. Tso: Polonium-210. A questionable risk factor in smoking-related carcinogenesis; in: A safe cigarette? Banbury Report 3 edited by G.B. Gori and F.G. Bock Cold Spring Harbor Laboratory Cold Spring Harbor N.Y. 1980 pp. 93–104.

  • 43. Dorland I. and (W.A. Newman): Dorland's illustrated medical dictionary 27th Edition edited by E.J. Taylor W.B. Saunders Company Philadelphia PA 1988.

  • 44. Dorland I.: Dorland's illustrated medical dictionary 13th Edition; W.B. Saunders Company Philadelphia PA 1927.

  • 45. Wynder E.L. and D. Hoffmann: Selected laboratory methods in tobacco carcinogenesis; in: Methods in cancer research. Vol. 4 edited by H. Busch Academic Press New York N.Y. 1968 pp. 3–52.

  • 46. Wynder E.L. and D. Hoffmann: Bioassays in tobacco carcinogenesis; Prog. Exp. Tumor Res. 11 (1969) 163–193.

  • 47. Hoffmann D. and E.L. Wynder: A study of tobacco carcinogenesis. XV. Chemical composition and tumorigenicity of tobacco smoke; in: The chemistry of tobacco and tobacco smoke edited by I. Schmeltz Plenum Publishing Co. 1972 pp. 123–147.

  • 48. Shear M.J. and J. Leiter: Studies in carcinogenesis. XVI. Production of subcutaneous tumors in mice by miscellaneous polycyclic compounds; J. Natl. Cancer Inst. 2 (1941) 241–258.

  • 49. Hartwell J.L.: Survey of compounds which have been tested for carcinogenic activity; USPHS Publ. No. 149 2nd Edition Washington D.C. 1951 pp. 1–2.

  • 50. Registry of Toxic Effects of Chemical Substances: 1985–1986 Edition user's guide; DHHS Publ. No. (PHS) (1987) 87–114.

  • 51. Gori G.B.: Less hazardous cigarettes: Theory and practice; in: A safe cigarette? Banbury Report 3 edited by G.B. Gori and F.G. Bock Cold Spring Harbor Laboratory Cold Spring Harbor N.Y. 1980 pp. 261–279.

  • 52. Hoffmann D. M.V. Djordjevic and K.D. Brunne-mann: Changes in cigarette design and composition over time and how they influence the yields of smoke constituents; J. Smoking-Related Dis. 6 (1995) 9–23; Hoffmann D. M.V. Djordjevic and I. Hoffmann: The changing cigarette; Prev. Med. 26 (1997) 427–434.

  • 53. Sugimura T.: Past present and future of mutagens in cooked foods; Environmental Hlth. Perspect. 67 (1986) 5–10.

  • 54. Coultson F.: Overall view of the conference; in: Human epidemiology and animal laboratory correlations in chemical carcinogenesis edited by F. Coult-son and P. Shubik Ablex Publishing Corporation Norwood N.J. 1980 pp. 395–402.

  • 55. Rozman K.K. and C.D. Klaassen: Absorption distri-bution and excretion of toxicants; in: Casarett and Doull's toxicology: The basic science of poison edited by C.D. Klaassen McGraw-Hill New York N.Y. 1996 pp. 91–112.

  • 56. Maga J.A.: Potential health concerns associated with smoke; in: Smoke in food processing by J.A. Maga CRC Press Inc. Boca Raton FL 1988 pp. 113–144.

  • 57. Waldman J.M. P.J. Lioy A. Greenberg and J.P. Butler: Analysis of human exposure to benzo[a]pyrene [sic] via inhalation and food ingestion in the total human exposure study (THEES); J. Exptl. Anal. Environ. Epidemiol. 1 (1991) 93–225.

  • 58. Hattemeyer-Frey H.A. and C.C. Travis: Benzo-a-pyrene [sic]: Environmental partitioning and human exposure; Toxicol. Ind. Hlth. 7 (1991) 141-157.

  • 59. Kazerouni N. R. Sinha C.-H. Hsu A. Greenberg and N. Rothman: Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study; Food Chem. Toxicol. 39 (2001) 423-436.

  • 60. Fieser L.F.: Chemical carcinogenesis; Arthur Stolle Festschrift (1957) 489-498.

  • 61. Grasso P.: Carcinogens in food; in: Chemical carcino-gens Second edition edited by CE. Searle American Chemical Society Monograph 182 American Chemical Society Washington D.C. 1984 Chapter 19 pp. 1205-1239.

  • 62. Neish W.J.P.: [Solubility of PAHs in aqueous purine solutions (caffeine theobromine xanthine)]; Rec. Trav. Chim. 67 (1948) 361.

  • 63. Rothwell K. and J.K. Whitehead: Complex formation isolation and carcinogenicity of polycyclic aromatic hydrocarbons; Nature 213 (1967) 797; A method for the isolation of polycyclic aromatic hydrocarbons from complex hydrocarbon mixtures; Chem. and Ind. (London) (1967) 784-786; A method for the concen-tration of basic polycyclic heterocyclic compounds and the separation of polycyclic aromatic hydrocarbons from cigarette smoke condensate; Chem. and Ind. (London) (1969) 1628-1630.

  • 64. Phillips D.H.: Polycyclic aromatic hydrocarbons in the diet; Mutat. Res. 443 (1999) 139-147.

  • 65. Lijinsky W.: N-Nitroso compounds in the diet; Mutat. Res. 443 (1999) 129-138.

  • 66. Keating. G.A. D.W. Layton and J.S. Felton: Factors determining dietary intake of heterocyclic amines in cooked foods; Mutat. Res. 443 (1999) 149-156

  • 67. Rojas E. L.A. Herrera L.A. Poirier and P. Ostrowsky-Wegman: Are metals dietary carcinogens? Mutat. Res. 443 (1999) 157-181.

  • 68. Ferguson L.R.: Natural and man-made mutagens and carcinogens in the human diet; Mutat. Res. 443 (1999) 1-10.

  • 69. Huber G.L.: Physical chemical and biological proper-ties of tobacco cigarette smoke and other tobacco products; in: Tobacco and smoking cessation. I edited by G.L. Huber Sem. Resp. Med. 10 (1989) 297-332: see p. 312 Table 5.

  • 70. Wattenberg L.W.: Chemoprevention of cancer; Cancer Res. 45 (1985) 1-8.

  • 71. Mirvish S.S.: Ascorbic acid inhibition of N-nitroso compound formation in chemical food and biological systems; in: Inhibition of tumor induction and devel-opment edited by M.S. Zedeck and M. Lipkin Plenum Publishing Corp. New York N.Y. 1981 pp. 101-126; Inhibition of the formation of carcinogenic N-nitroso compounds by ascorbic acid and other compounds; in: Cancer achievements challenges and prospects for the 1980's edited by J.H. Burchenal and H.F. Oettgen Plenum Publishing Corp. New York N.Y. pp. 557-588.

  • 72. Newmark H. and W. Mergens: a-Tocopherol (vitamin E) and its relationship to tumor induction; in: Inhibition of tumor induction and development edited by M.S. Zedeck and M. Lipkin Plenum Publishing New York N.Y. 1981 pp. 127-168.

  • 73. Kuenzi W. J. Chau E. Norkus H. Holowaschenko H. Newmark W. Mergens and A.N. Conney: Caffeic and ferulic acid as blockers of nitrosamine formation; Carcinogenesis 5 (1984) 309-314.

  • 74. Wattenberg L.W.: Inhibition of dimethylhydrazine-induced neoplasia of the large intestine by disulfiram; J. Natl. Cancer Inst. 54 (1975) 1005-1006.

  • 75. Fiala E.S. G. Bobotas C. Kulakis L.W. Wattenberg and J.H. Weisburger: The effect of disulfiram and related compounds on the in vivo metabolism of the colon carcinogen 12-dimethylhydrazine; Biochem. Pharmacol. 26 (1977) 1763-1768.

  • 76. Slaga T.J. and J. DiGiovanni: Inhibition of chemical carcinogenesis; in: Chemical carcinogens 2nd Edition edited by CE. Searle American Chemical Society Monograph 182 American Chemical Society Washington D.C. 1984 pp. 1279-1321.

  • 77. Crabtree H.G.: Influence of bromobenzene on the induction of skin tumors by 34-benzopyrene; Cancer Res. 4 (1944) 688-693; Influence of unsaturated dibasic acids on the induction of skin tumors by chemical carcinogens; Cancer Res. 5 (1945) 346-351; Some effects of aromatic hydrocarbons on sulfur metabolism and tumor induction in mice; Cancer Res. 6 (1946) 553-559; Anticarcinogenesis; Brit. Med. Bull. 4 (1947) 345-348.

  • 78. Steiner P.E. and H.L. Falk: Summation and inhibition effects of weak and strong carcinogenic hydrocarbons 1:2-benzanthracene chrysene 1:2:5:6-dibenzanthra-cene and 20-methylcholanthrene; Cancer Res. 11 (1951) 56-63.

  • 79. Dipple A. R.C. Moschel and C.A.H. Bigger: Poly-nuclear hydrocarbons; in: Chemical carcinogens Second edition edited by CE. Searle American Chemical Society Monograph 182 American Chemical Society Washington D.C 1984 Chapter 2 pp. 41-163.

  • 80. Slaga T.J. L. Jecker W.M. Bracken and CE. Weeks: The effects of weak or non-carcinogenic poly-cyclic hydrocarbons on 712-dimethylbenz[a]anthra-cene and benzo[a]pyrene; Cancer Lett. 7 (1979) 51-59.

  • 81. DiGiovanni J. T.J. Slaga D.L. Berry and M.R. Juchau: Inhibitory effects of environmental chemicals on polycyclic aromatic hydrocarbon carcinogenesis; in: Carcinogenesis. A comprehensive survey. Vol. 5 edited by T.J. Slaga Raven Press New York N.Y. 1980 pp. 145-168.

  • 82. Snook M.E. R.F. Severson R.F. Arrendale H.C. Higman and O.T. Chortyk: The identification of high molecular weight polynuclear aromatic hydrocarbons in a biologically active fraction of cigarette smoke condensate; Beitr. Tabakforsch. Int. 9 (1977) 79-101.

  • 83. Williams D. F.I. Wiebel J.C Leutz and H.V. Gelboin: [phenanthrene/anthracene inhibition of hydroxylation-epoxidation of BaP in hepatic micro-somes]; Biochem. Pharmacol. 20 (1971) 2130.

  • 84. Rodgman A. and L.C Cook: The analysis of cigarette smoke condensate. XIV. Polycyclic aromatic hydrocarbons; RJRT RDR 1960 No. 20 May 26: see www.rjrtdocs.com 501008592 -8660.

  • 85. Slaga T.J. and R.K. Boutwell: Inhibition of the tumor-initiating ability of the potent carcinogen 712-dimethylbenz[a]anthracene by the weak tumor initia-tor 1234-dibenzanthracene; Cancer Res. 37 (1977) 129-133.

  • 86. Slaga T.J. A. Viaje S.G. Buty and W.M. Bracken: Dibenz[ac]anthracene: A potent inhibitor of skin-tumor initiation by 712-dimethylbenz[a]anthracene; Res. Comm. Chem. Pathol. Pharmacol. 19 (1978) 477-483.

  • 87. Lacassagne A. N.P. Buu-Hoï and G. Rudall: Inhibition of the carcinogenic action produced by a weakly carcinogenic hydrocarbon on a highly active hydrocarbon; Brit. J. Exptl. Path. 26 (1945) 5-12.

  • 88. Hill W.T. DW. Stanger A. Pizzo B. Riegel P. Shubik and W.B. Wartman; Cancer Res. 11 (1951) 892-897.

  • 89. Badger G.M.: Chemical constitution and carcinogenic activity; Adv. Cancer Res. 2 (1954) 73-127.

  • 90. Homburger F. A. Treger and E. Boger: Experimental studies on the inhibition of carcinogenesis by cigarette-smoke condensates and carcinogen-related substances; in: Toward a less harmful cigarette Proceedings of Workshop on Smoking and Health September 1967 edited by E.L. Wynder and D. Hoffmann. Natl. Cancer Inst. Monograph 28 Washington D.C 1968 pp. 259-270.

  • 91. Wynder E.L. and D. Hoffmann: A study of air pollution carcinogenesis. III. Carcinogenic activity of gasoline engine exhaust condensate; Cancer 15 (1962) 103-108.

  • 92. Eatough D.J. L.D. Hansen and E.A. Lewis: The chemical characterization of environmental tobacco smoke; in: Environmental tobacco smoke edited by D.J. Ecobichon and J.M. Wu Proc. International Symposium at McGill University PQ Canada 1989 Lexington Books D.C. Heath and Company Lexing-ton MA 1990 pp. 3-39.

  • 93. Rodgman A. and L.C. Cook: The composition of cigarette smoke. IV. a-Tocopherol; Tob. Sci. 4 (1960) 7-8.

  • 94. Rodgman A. and L.C. Cook: The composition of cigarette smoke. XI. Heterocyclic nitrogen compounds from Turkish tobacco smoke; Tob. Sci. 6 (1962) 176-179.

  • 95. Izard C J. LaCharpagne and P. Testa: Sur l'activité biologique de divers condensats de fumée de ciga-rettes revelée par les tests auxiniques; Compt. Rend. 262D (1966) 1859-1861.

  • 96. Rowland R.L. A. Rodgman J.N. Schumacher D.L. Roberts L.C. Cook and Walker W.E. Jr.: Macro-cyclic diterpenes. Hydroxyethers from tobacco and tobacco smoke; 17th Tobacco Chemists’ Research Conference Program Booklet and Abstracts Vol. 17 Paper No. 16 1963 p. 13; Macrocyclic diterpene hydroxyethers from tobacco and cigarette smoke; J. Org. Chem. 29 (1964) 16-21.

  • 97. Falk H.L. P. Kotin and S. Thompson: Inhibition of carcinogenesis. The effect of hydrocarbons and related compounds; Arch. Environ. Hlth. 9 (1964) 169-179.

  • 98. Hoffman H.E. and A.C. Griffin: Action of cigarette tar and smoke on chemically induced carcinogenesis; Texas Rep. Biol. Med. 16 (1958) 333–345.

  • 99. Wynder E.L. and D. Hoffmann: Experimental tobacco carcinogenesis; Adv. Cancer Res. 8 (1964) 249–453: see p. 296 330.

  • 100. Kotin P. and H.L. Falk: Atmospheric factors in patho-genesis of lung cancer; Adv. Cancer Res. 7 (1953) 475–514: see pp. 489–490.

  • 101. Wynder E.L. and D. Hoffmann: Studies with gaseous and particulate phase of cigarette smoke; Proc. Am. Assoc. Cancer Res. 3(4) (1962) 373; Bioassays on the carcinogenicity of tobacco smoke condensate and air pollutants; Proc. Am. Assoc. Cancer Res. 4(1) (1963) 73.

  • 102. Wynder E.L. and D. Hoffmann: Biological and chemical studies of tobacco smoke condensate; Proc. Am. Assoc. Cancer Res. 3(3) (1961) 280.

  • 103. Wynder E.L. and G.F Wright: A study of tobacco carcinogenesis. I. The primary fractions; Cancer 10 (1957) 255–271.

  • 104. Lam J.: 34-Benzopyrene as a product of the pyrolysis of aliphatic hydrocarbons; Acta Path. Microbiol. Scand. 37 (1955) 421–428.

  • 105. Wynder E.L.: Human and experimental relation of tobacco and cancer; Tobacco Symposium Long Island Subsection American Chemical Society 1956.

  • 106. Wright G.F: Personal communication. [See Rodgman A.: Tobacco tar fractionation and the pretreatment of tobacco: A conversation with Dr. George F Wright of the University of Toronto Toronto ON Canada; RDM 1957 No. 25 July 22: see www.rjrtdocs.com 500610651 -0656].

  • 107. Wynder E.L. G.F Wright and J. Lam: A study of tobacco carcinogenesis. V. The role of pyrolysis; Proc. Am. Assoc. Cancer Res. 2(4) (1958) 357–358; Cancer 11 (1958) 1140–1148.

  • 108. Wynder E.L. G.F Wright and J. Lam: A study of tobacco carcinogenesis. VI. The role of precursors; Cancer 12 (1959) 1073–1078.

  • 109. Rodgman A.: The analysis of cigarette smoke con-densate. II. The pretreatment of Camel blend tobacco; RDR 1956 No. 12 November 1: see www.rjrtdocs.com 501008294 -8336; The analysis of cigarette smoke condensate. III. Flue-cured tobacco; RDR 1957 No. 4 March 14: see www.rjrtdocs.com 501008337 –8377; Some studies on the effects of additives on cigarette mainstream smoke properties. I. Flavorants; Beitr. Tabakforsch. Int. 20 (2001) 83–103.

  • 110. Wynder E.L. and D. Hoffmann: The role of higher polycyclic hydrocarbons in tobacco carcinogenesis; Proc. Am. Assoc. Cancer Res. 3(1) (1959) 74; A study of tobacco carcinogenesis. VII. The role of higher polycyclic hydrocarbons; Cancer 12 (1959) 1079–1086.

  • 111. Wynder E.L. and D. Hoffmann: Biological and chemical studies of tobacco smoke condensate; Proc. Am. Assoc. Cancer Res. 3(3) (1961) 280; Studies with the gaseous and particulate phase of tobacco smoke; Proc. Am. Assoc. Cancer Res. 3(4) (1962) 373.

  • 112. Hoffmann D. and E.L. Wynder: A study of air pollution carcinogens. II. The isolation and identification of polynuclear aromatic hydrocarbons from gasoline engine exhaust condensate; Cancer 15 (1962) 93–102.

  • 113. Wynder E.L. and D. Hoffmann: Experimental tobacco carcinogenesis; Adv. Cancer Res. 8 (1964) 249–453.

  • 114. Homburger F.: Les rapports entre tabac et cancer: pathologie expérimentale; Med. Hyg. (Switz.) 23 (1965) 179–181; Homburger F. and A. Treger: Effects of intravenous carcinogen and tobacco conden-sate injections upon the incidence of lung tumors in A/He mice; in: Lung tumors in animals edited by L. Severi Division of Cancer Research University of Perugia Italy 1965 pp. 527–536; Homburger F. A. Treger and E. Boger: Experimental studies on the inhibition of carcinogenesis by cigarette-smoke condensates and carcinogen-related substances; in: Toward a less harmful cigarette edited by E.L. Wyn-der and D. Hoffmann Natl. Cancer Inst. Monograph 28 (1968) 259–270; Inhibition of murine subcutaneous and intravenous benzopentaphene carcinogenesis by sweet orange oils and d-limonene; Oncology 25 (1971) 1–10.

  • 115. Rothwell K. and J.K. Whitehead: A method for the concentration of basic polycyclic heterocyclic com-pounds and the separation of polycyclic aromatic hydrocarbons from cigarette smoke condensate; Chem. and Ind. (London) (1969) 1628–1630.

  • 116. Snook M.E. R.F. Arrendale H.C. Higman and O.T. Chortyk: Isolation of indoles and carbazoles from cigarette smoke condensate; Anal. Chem. 50 (1978) 88–90; Snook M.E. P.J. Fortson L.B. Smith and O.T. Chortyk: Isolation and identification of aza-arenes of tobacco smoke; 32nd Tobacco Chemists’ Research Conference Program Booklet and Abstracts Vol. 32 Paper No. 46 1978 p. 25; Snook M.E. P.J. Fortson and O.T. Chortyk: Isolation and identification of aza-arenes of tobacco smoke; Beitr. Tabakforsch. Int. 11 (1981) 67–78.

  • 117. Wynder E.L. and D. Hoffmann: Tobacco and tobacco smoke: Studies in experimental carcinogenesis; Academic Press New York N.Y. 1967 pp. 245–247 628.

  • 118. Homburger F. and A. Treger: Effects of intravenous carcinogen and tobacco condensate injections upon the incidence of lung tumors in A/He mice; in: Lung tumors in animals edited by L. Severi Division of Cancer Research University of Perugia Italy 1965 pp. 527–536.

  • 119. Wynder E.L. and D. Hoffmann: Tobacco and tobacco smoke: Studies in experimental carcinogenesis; Academic Press New York N.Y. 1967 pp. 628–629.

  • 120. Wynder E.L. and D. Hoffmann: A study of air pollution carcinogenesis. III. Carcinogenic activity of gasoline engine exhaust condensate; Cancer 15 (1962) 103–108.

  • 121. Wynder E.L. and D. Hoffmann: Studies with the gaseous and particulate phase of tobacco smoke; Proc. Am. Assoc. Cancer Res. 3(4) (1962) 373; Tobacco and tobacco smoke: Studies in experimental carcino-genesis; Academic Press New York N.Y. 1967 pp. 370–371 628–629.

  • 122. Homburger F.: Les rapports entre tabac et cancer: Pathologie expérimentale; Med. Hyg. (Switz.) 23 (1965) 179–181.

  • 123. Homburger F. A. Treger and E. Boger: Experimental studies on the inhibition of carcinogenesis by cigarette-smoke condensates and carcinogen-related substances; in: Toward a less harmful cigarette; Proceedings of Workshop on Smoking and Health September 1967 edited by E.L. Wynder and D. Hoffmann Natl. Cancer Inst. Monograph 28 (1968) 259-270.

  • 124. Rowland R.L.: Flue-cured tobacco. III. Solana-chromene and a-tocopherol; J. Am. Chem. Soc. 80 (1958) 6130-6133.

  • 125. Rodgman A. and L.C. Cook: The composition of cigarette smoke. XI. Heterocyclic nitrogen compounds from Turkish tobacco smoke; 16th Tobacco Chemists’ Research Conference Program Booklet and Abstracts Vol. 16 Paper No. 23 1962 p. 14; Tob. Sci. 6 (1962) 176-179.

  • 126. Roberts D.L. and R.L. Rowland: Macrocyclic diter-penes. a- and P-4813-duvatriene-13-diols from tobacco; J. Org. Chem. 27 (1962) 3989-3995.

  • 127. Saito Y. H. Takizawa S. Konishi D. Yoshida and S. Mizusaki: Identification of cembratriene-46-diol as a antitumor-promoting agent from cigarette smoke condensate; Carcinogenesis 6 (1985) 1189-1194.

  • 128. Clemo G.R.: Some aspects of the chemistry of tobacco smoke. I; Tetrahedron 3 (1958) 168-174; Kosak A.I. and P.D. Rosen: Components of cigarette smoke; 7th International Cancer Congress London England 1958; Kosak A.I. P.D. Rosen and J.S. Swinehart: Components of cigarette smoke; Acta Unio Internat. Contra Cancrum 15 (1959) 612.

  • 129. Green C.R. and A. Rodgman: The Tobacco Chemists’ Research Conference: A half century forum for advances in analytical methodology of tobacco and its products; Recent Adv. Tob. Sci. 22 (1996) 131-304.

  • 130. Fay J.R. L.R. Perry L.A. Kanerva CC. Sigman and C.T. Helmes: Inhibitors of chemical carcinogenesis; Document prepared in 1984 revised in 1985 for Sci. Coordinator Environ. Cancer National Cancer Insti-tute Bethesda MD 1985 pp. 1-96.

  • 131. Denissenko M.F. A. Pao M. Tang and G.P. Pfeifer: Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53; Science 274 (1996) 430-432.

  • 132. Jerina D.M. R. Lehr M. Schaefer-Ridden H. Yagi J.M. Karle D.R. Thakker A.W. Wood A.Y.H. Lu D. Ryan S. West W. Levi and A.H. Connery: in: Origins of human cancer edited by H.H. Hiatt J.D Watson and J.A. Winston Cold Spring Harbor Laboratory N.Y. 1977 p. 639.

  • 133. Lee CK. and E.A. Reed: Ames test on smoke condensates: A summary; RJRT R&DM 1983 No. 20 May 9: see www.rjrtdocs.com 508352301 -2303.

  • 134. Murphy S.E. and R. Heilbrun: Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N’-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue; Carcinogenesis 11 (1990) 1663-1666.

  • 135. Lee CK. C.W. Fulp D.W. Bombick and D.J. Doolittle: Nicotine and cotinine inhibit the muta-genicity of N-nitrosamines present in tobacco smoke; 48th Tobacco Chemists’ Research Conference Paper No. 44; Vol. 48 Paper No. 44 1994 p. 51; Inhibition of mutagenicity of N-nitrosamines by tobacco smoke and its constituents; Mutat. Res. 367 (1996) 83–92.

  • 136. Brown B. J.T. Avalos C.K. Lee and D.J. Doolittle: The effect of tobacco smoke nicotine and cotinine on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL); 55th Tobacco Science Research Conference Program Booklet and Abstracts Vol. 55 Paper No. 10 2001 p. 26.

  • 137. Lee C.K. J.A. Munoz C.W. Fulp K.M. Chang J. Rogers M.F. Borgerding and D.J. Doolittle: Inhibitory activity of cigarette-smoke condensate on the mutagenicity of heterocyclic amines; Mutat. Res. 322 (1993) 21–32.

  • 138. Sugimura T. T. Kawachi M. Nagao T. Yohagi Y. Seino T. Okamoto K. Shudo T. Kosuge K. Tsuji K. Watabayashi Y. Iitaka and A. Ita: Mutagenic princi-ple(s) in tryptophan and phenylalanine pyrolysis products; Proc. Japan Acad. 53B (1977) 58–61; Sugimura T M. Nagao T. Kawachi M. Honda T. Yahagi Y. Seino S. Sato N. Matsukura T. Mat-sushima A. Shitai M. Sawamura and H. Matsumoto: Mutagens-carcinogens in food with special reference to highly mutagenic pyrolytic products in broiled foods; in: Origins of human cancer edited by H.H. Hiatt J.D. Watson and J.A. Winsten Cold Spring Harbor Labora-tory Cold Spring Harbor N.Y. 1977 pp. 1561–1577.

  • 139. Yamamoto T. K. Tsuji T. Kosuge T. Okamoto K. Shudo K. Takeda Y. Iitaka K. Yamaguchi Y. Seino T. Yahagi M. Nagao and T. Sugimura: Isolation and structure determination of mutagenic substances in L-glutamic acid pyrolysate; Proc. Japan Acad. 54B (1978) 248–250.

  • 140. Yamashita M. K. Wakabayashi M. Nagao S. Sato and N. Kinea: Amounts of heterocyclic amines in the basic fraction of cigarette smoke condensates; Environ. Mutagen Soc. Japan Mtg. Akita Japan: see Abstract in Mutat. Res. 164 (1986) 286; Yamashita M. K. Waka-bayashi M. Nagao S. Sato Z. Yamaizumi M. Taka-hashi N. Kinea I. Tomita and T. Sugimura: Detection of 2-amino-3-methylimidazo[45-f] q u i n o l i n e i n c i g a r e t t e smoke condensate; Gann 77 (1986) 419–422.

  • 141. Felton K.S. and M.G. Knize: Heterocyclic amine mutagens/carcinogens in foods; in: Chemical mutagene-sis and carcinogenesis edited by C.S. Cooper and P.L. Grover Springer-Verlag Berlin/Heidelberg 1990 pp. 471–502.

  • 142. Van Duuren B.L.: The polynuclear aromatic hydro-carbons in cigarette-smoke condensate. II; J. Natl. Cancer Inst. 21 (1958) 623–630: see Footnote added in proof p. 629.

  • 143. Lavit-Lamy D. and N.P. Buu-Hoï: The true nature of “dibenzo[al]pyrene” and its known derivatives; Chem. Comm. 4 (1966) 92–94.

  • 144. IARC: Polynuclear aromatic compounds Part 1 Chemical environmental and experimental data; in: IARC Monographs on the evaluation of the carcino-genic risk of chemicals to humans Monograph 32 (1983) 321–325.

  • 145. National Cancer Institute: Report No. 5. Toward less hazardous cigarettes. Summary: Four skin painting bioassays using condensate from experimental ciga-rettes; DHEW Publ. (NIH) (September 1980).

  • 146. Rodgman A.: Studies of polycyclic aromatic hydro-carbons in cigarette mainstream smoke: Identification tobacco precursors control of levels: A review; Beitr. Tabakforsch. Int. 19 (2001) 361–379.

  • 147. Wynder E.L.: Statement on lung cancer-cigarette smoking controversy: Chemical fractionation of cigarette smoke condensate; in: False and misleading advertising (Filter-tip cigarettes) Wynder reported on the studies of G.F Wright at the Hearing before Subcommittee on Government Operations (the Blatnik Hearings on Filtered Cigarettes) (July 1957) pp. 63–114.

  • 148. Hecht S.S.: Tobacco smoke carcinogens and lung cancer; J. Natl. Cancer Inst. 91 (1999) 1194–1210.

  • 149. Snook M.E. R.F. Severson H.C. Higman R.F. Arrendale and O.T. Chortyk: Polynuclear aromatic hydrocarbons of tobacco smoke: isolation and identification; Beitr. Tabakforsch. 8 (1976) 250–272.

  • 150. Snook M.E. R.F. Severson R.F. Arrendale H.C. Higman and O.T. Chortyk: Multi-alkylated poly-nuclear aromatic hydrocarbons of tobacco smoke: separation and identification; Beitr. Tabakforsch. Int. 9 (1978) 222–247.

  • 151. Heckman R.A. and F.W. Best: An investigation of the lipophilic bases of cigarette smoke condensate; Tob. Sci. 25 (1981) 33–39.

  • 152. Newell M.P. R.A. Heckman R.F. Moates C.R. Green F.W. Best and J.N. Schumacher: Isolation and identification of new components of the ether-soluble portion of cigarette smoke condensate; Tob. Sci. 22 (1978) 6–11.

  • 153. Schumacher J.N. C.R. Green F.W. Best and M.P. Newell: Smoke composition. An extensive investigation of the water-soluble portion of cigarette smoke; J. Agr. Food Chem. 25 (1977) 310–320.

  • 154. Binder H.: Ethylene oxide and chlorohydrin in tobacco and in smoke; Fachliche Mitt. Österr. Tabak-regie 15 (1974) 294–301.

  • 155. Binder H. and W. Lindner: Bestimmung von Äthylen-oxid im Rauch garantiert unbegaster Zigaretten; Fachliche Mitt. Österr. Tabakregie 13 (1972) 215–220.

  • 156. Deutsch-Wenzel R.P. H. Brune G. Grimmer G. Dettbarn and J. Misfeld: Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring polycyclic aromatic hydrocarbons; J. Natl. Cancer Inst. 71 (1983) 539–544.

  • 157. Adams J.D. K.J. O'Mara-Adams and D. Hoffmann: On the mainstream-sidestream distribution of smoke components from commercial cigarettes; 39th Tobacco Chemists’ Research Conference Program Booklet and Abstracts Vol. 39 Paper No. 34 1985 p. 18; Toxic and carcinogenic agents in undiluted main-stream smoke and sidestream smoke of different types of cigarettes; Carcinogenesis 8 (1987) 729–731.

  • 158. Wynder E.L. L. Fritz and N. Furth: Effect of concen-tration of benzopyrene in skin carcinogenesis; J. Natl. Cancer Inst. 19 (1957) 361–370.

  • 159. Poel W.E.: Carcinogens and minimal carcinogenic doses; Science 123 (1956) 588.

  • 160. Poel W.E. and A.G. Kammer: Preliminary studies in a quantitative approach to skin carcinogenesis; J. Natl. Cancer Inst. 16 (1958) 989–994.

  • 161. Hecht S.S. W.E. Bondinell and D. Hoffmann: Isolation and identification of alkylchrysenes in cigarette smoke; 27th Tobacco Chemists’ Research Conference Program Booklet and Abstracts Vol. 27 Paper No. 32 1973 p. 23; Chrysene and methyl-chrysenes: Presence in tobacco smoke and carcino-genicity; J. Natl. Cancer Inst. 53 (1974) 1121–1133.

  • 162. Wynder E.L. and D. Hoffmann: Ein experimenteller Beitrag zur Tabakrauchkanzerogenese; Deut. Med. Wchnschr. 88 (1963) 623–628.

  • 163. Dobrowolskaïa-Zavadskaïa N.: Doses of 1256-dibenzanthracene capable of producing cancer in mice; Comp. Rend. Soc. Biol. 129 (1938) 1055.

  • 164. Lyons M.J. and H. Johnston: Chemical analysis of the neutral fraction of cigarettes smoke tar; Brit. J. Cancer 11 (1957) 554–562.

  • 165. Candeli A. D. Hoffmann and E.L. Wynder: Unpub-lished data cited in E.L. Wynder and D. Hoffmann: Experimental tobacco carcinogenesis; Adv. Cancer Res. 8 (1964) 249–453: see 323–333; also cited in Wynder E.L. and D. Hoffmann: Tobacco and tobacco smoke: Studies in experimental carcinogenesis; Academic Press New York N.Y. 1967: see 373–374 Table VIII-14.

  • 166. Schmeltz I. W.S. Schlotzhauer and E.B. Higman: Characteristic products from pyrolysis of nitrogenous organic substances; Beitr. Tabakforsch. 6 (1972) 134–138.

  • 167. Schmeltz I. A. Wenger D. Hoffmann and T.C. Tso: Chemical studies on tobacco smoke. 63. On the fate of nicotine during pyrolysis and in a burning cigarette; J. Agr. Food Chem. 27 (1979) 602–608.

  • 168. Snook M.E.: Nitrogen analogues of polynuclear aromatic hydrocarbons in tobacco smoke; in: Carcino-genesis: polynuclear aromatic hydrocarbons. Vol. 3 edited by P.W. Jones and R.I. Freudenthal Raven Press New York N.Y. 1978 pp. 203–215.

  • 169. Grimmer G. K.W. Naujack and G. Dettbarn: Gas chromatographic determination of polycyclic aromatic hydrocarbons aza-arenes aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes; Internat. Exptl. Toxicol. Symp. on Passive Smoking Essen FRG; Gas chromato-graphic determination of polycyclic aromatic hydro-carbons aza-arenes aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes; Toxicol. Lett. 35 (1987) 117–124.

  • 170. Kaburaki Y. S. Sugawara U. Kobashi and T. Doi-hara: Studies on the composition of tobacco smoke. XIV. The formation of pyridines in the pyrolysis of nicotine; J. Agr. Chem. Soc. Japan 44 (1970) 224–231.

  • 171. Caldwell W. S. and J.M. Conner: Artifact formation during smoke trapping. An improved method for the determination of N-nitrosamines in cigarette smoke; 43rd Tobacco Chemists’ Research Conference Program Booklet and Abstracts Vol. 43 Paper No. 45 1989 p. 37; Caldwell W.S. and J.M. Conner: Artifact formation during smoke trapping: An im-proved method for the determination of N-nitros-amines in cigarette smoke; J. Assoc. Official Anal. Chem.. 73 (1990) 783-789.

  • 172. Environmental Protection Agency: Maleic hydrazide: Notification of issuances of notice of intent to suspend pesticide registrations; Fed. Reg. 46 (No. 179) (1981) 46000.

  • 173. Griffin H.R. M.B. Hocking and D.G. Lowery: Arsenic determination in tobacco by atomic absorption spectrometry; Anal. Chem. 47 (1975) 229-233.

  • 174. Hoffmann D. K.D. Brunnemann J.D. Adams and S.S. Hecht: Formation and analysis of N-nitrosamines in tobacco products and their endogenous formation in consumers; in: N-Nitroso compounds: Occurrence biological effects and relationship to human cancer edited by I.K. O'Neill R.C. von Borstel C.T. Miller J. Long and H. Bartsch IARC Lyon France IARC Sci. Publ. No. 57 1984 pp. 743-762.

  • 175. Hecht S.S. and D. Hoffmann: 4-(N-Methylnitros-amino)-1-(3-pyridyl)-1-butanone a nicotine-derived tobacco-specific nitrosamine and cancer of the lung and pancreas in humans; in: The origins of human cancer: A comprehensive review edited by J. Brugge T. Curran E. Harlow and F. McCormick Cold Spring Harbor Laboratory Cold Spring Harbor N.Y. 1991 pp. 745-755.

  • 176. IARC: 2-Naphthylamine; IARC Lyon France IARC Monograph 4 (1974) 97-111.

  • 177. Hoffmann D. Y. Masuda and E.L. Wynder: a-Naphthylamine and (3-naphthylamine in cigarette smoke; Nature 221(1969) 254-256.

  • 178. Schmeltz I. and D. Hoffmann: Nitrogen-containing compounds in tobacco and tobacco smoke; Chem. Rev. 77 (1977) 295-311.

  • 179. IARC: 4-Aminobiphenyl; IARC Lyon France IARC Monograph 1 (1972) 74-79.

  • 180. IARC: Formaldehyde; IARC Lyon France IARC Monograph [Suppl. 4] (1982) 131-132.

  • 181. Dalhamn T. M.L. Edfors and R. Rylander: Mouth absorption of various compounds in cigarette smoke; Arch. Environ. Hlth. 16 (1968) 831-835; Retention of cigarette smoke components in human lungs; Arch. Environ. Hlth. 17 (1968) 746-748.

  • 182. IARC: Benzene; IARC Lyon France IARC Monograph 7 (1974) 203-211; Benzene; IARC Lyon France IARC Monograph 29 (1982) 93-148.

  • 183. Shubik P. and J.L. Hartwell: Survey of compounds which have been tested for carcinogenic activity; Suppl. 1 USPHS Publ. No. 149 Washington D.C. 1957; Suppl. 2 USPHS Publ. No. 149 Washington D.C. 1969.

  • 184. Thomas J.I. et al: Survey of compounds which have been tested for carcinogenic activity; USPHS Publ. No. 149 Washington D.C. 1968/1969; 1970/1971.

  • 185. IARC: Acrylonitrile; IARC Lyon France IARC Monograph 19 (1979) 73-113.

  • 186. IARC: Vinyl chloride; IARC Lyon France IARC Monograph 19 (1979) 377-438.

  • 187. Schepartz A.I.: The chemistry of cigar smoke. II. Some components of the neutral fraction; Tob. Sci. 4 (1960) 12-16.

  • 188. Dymicky M. O.T. Chortyk and R.L. Stedman: Composition studies on tobacco. XXVII. Polyphenol-amino acid leaf pigment: Further structural investigations; Tob. Sci. 11 (1967) 42–44; Dymicky M. and R.L. Stedman: Composition studies on tobacco. XXV. Moieties in a high molecular weight smoke pigment: Alkaloids and a silicone; Phytochem. 6 (1967) 1025–1031.

  • 189. Nesemann E. R. Schröder and F. Seehofer: Metho-den zur quantitativen Bestimmung von Insektiziden in Tabak und Tabakrauch. I. Mitteilung: Zur Bestim-mung von Organo-Chlor-Insektiziden; Beitr. Tabak-forsch. 4 (1968) 182–188.

  • 190. Hoffmann D. G. Rathkamp and E.L. Wynder: Chemical studies on tobacco smoke. IX. Quantitative analysis of chlorinated hydrocarbon insecticides; Beitr. Tabakforsch. 5 (1969) 140–148.

  • 191. IARC: Hydrazine; IARC Lyon France IARC Mono-graph 4 (1974) 127–136 173–175.

  • 192. Cogbill E.C. and M.E. Hobbs: The transfer of metal-lic constituents to the mainstream smoke; Tob. Sci. 1 (1957) 68–73.

  • 193. Satterlee H.S.: The problem of arsenic in American cigarettes; New Eng. J. Med. 254 (1956) 1149–1154.

  • 194. IARC: Arsenic and arsenic compounds; IARC Lyon France IARC Monograph 23 (1980) 39–141.

  • 195. IARC: Nickel and inorganic nickel compounds; IARC Lyon France IARC Monograph 3 (1973) 126–149.

  • 196. IARC: Chromium and chromium compounds; IARC Lyon France IARC Monograph 23 (1980) 205–323.

  • 197. IARC: Lead and lead compounds; IARC Lyon France IARC Monograph 23 (1980) 325–415.

  • 198. Grimmer G. H. Brune R. Deutsch-Wenzel K.W. Naujack J. Misfeld and J. Timm: On the contribution of polycyclic aromatic hydrocarbons to the carcino-genic impact of automobile exhaust condensate evaluated by local application onto mouse; Cancer Lett. 21 (1983) 105–113.

  • 199. Grimmer G. H. Brune R. Deutsch-Wenzel G. Dettbarn and J. Misfeld: Contribution of polycyclic aromatic hydrocarbons to the carcinogenic impact of gasoline engine exhaust condensate evaluated by implantation into the lungs of rats; J. Natl. Cancer Inst. 72: (1984) 733–739.

  • 200. Grimmer G. H. Brune R. Deutsch-Wenzel G. Dettbarn J. Misfeld U. Abel and J. Timm: The contribution of polycyclic aromatic hydrocarbon fractions with different boiling ranges to the carcino-genic impact of emission condensate from coal fired residential furnaces as evaluated by topical application to the skin of mice; Cancer Lett. 28 (1985) 203–211.

  • 201. Tricker A.R.; N-Nitroso compounds and man: Sources of exposure endogenous formation and occurrence in body fluids; Eur. J. Cancer Prev. 6 (1997) 226–268.

  • 202. Preussmann R. and G. Eisenbrand: N-Nitroso carcino-gens in the environment; in: Chemical carcinogens. Second edition edited by C.E. Searle American Chemical Society Monograph 182 American Chemical Society Washington D.C. 1984 Chapter 13 pp. 829–868.

  • 203. Wattenberg L.W. and J.B. Coccia: Inhibition of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone carcino-genesis in mice by d-limonene and citrus fruit oils; Carcinogenesis 12 (1991) 115-117.

  • 204. Homburger F. A. Treger and E. Boger: Inhibition of murine subcutaneous and intravenous benzopenta-phene carcinogenesis by sweet orange oils and d-limonene; Oncology 25 (1971) 1-10.

  • 205. Waddell W. and C. Marlowe: Inhibition by alcohols of the localization of radioactive nitrosonornicotine in sites of tumor formation; Science 221 (1983) 51-52.

  • 206. Farinati F. Z. Zhou J. Bellah CS. Liebers and AJ. Garro: Effect of chronic ethanol consumption on acti-vation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract lung and hepatic tissue; Drug Metab. Dispos. 13 (1985) 210-214.

  • 207. Wattenberg L.W.: Inhibitors of chemical carcinogens; in: Cancer: Achievements challenges and prospects for the 1980’s edited by J.H. Burchenal Grune and Stratton New York N.Y. 1981 pp. 517-539.

  • 208. Takeda K. S. Ukawa and M. Mochizuki: Inhibition by fatty acids of direct mutagenicity of N-nitroso compounds; in: Relevance to human cancer of N-nitroso compounds tobacco and mycotoxins edited by I.K. O'Neill J. Chen and H. Bartsch IARC Lyon France IARC Sci. Publ. No. 105 (1991) 558-563.

  • 209. Chung F.L. A. Juchatz J. Vitarius and S.S. Hecht: Effects of dietary compounds on a-hydroxylation of N-nitrosopyrrolidine and N -nitrosonornicotine in rat target tissues; Cancer Res. 44 (1984) 2924.

  • 210. Chung F.L. A. Juchatz J. Vitarius B. Reiss and S.S. Hecht: Inhibition of target tissue activation of N’-nitrosonornicotine and N-nitrosopyrrolidine by dietary components; in: N-Nitroso compounds: Occurrence biological effects and relevance to human cancer edited by I.K. O'Neill R.C. von Borstel C.T. Miller J. Long and H. Bartsch IARC Lyon France IARC Sci. Publ. No. 57 (1984) 797-804.

  • 211. Van Duuren B.L. A. Sivak C. Katz and S. Mel-chionne: Cigarette smoke carcinogenesis: Importance of tumor promoters; J. Natl. Cancer Inst. 47 (1971) 235-240.

  • 212. Thompson H.J.: Effect of deficiencies of selenium and vitamin E alone or in combination on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea; Carcinogenesis 12 (1991) 2175-2179.

  • 213. Teel R. and A. Castonguay: Antimutagenic effects of polyphenolic compounds; Cancer Lett. 66 (1992) 107–113.

  • 214. Chung F.L. M.A. Morse K.I. Eklind and Y. Xu: Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea; in: Tobacco smoking and nutrition: Influence of nutrition on tobacco-associated health risks edited by J.N. Diana and W.A. Pryor Ann. N.Y. Acad. Sci. 686 (1993) 186–202.

  • 215. Schüller H.M. A. Castonguay M. Orloff and G. Rossignol: Modulation of the uptake and metabolism of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine; Cancer Res. 51 (1991) 2009–2114.

  • 216. Berry D.L. T.J. Slaga J. DiGiovanni and M.R. Juchau: Chlorinated dibenzo-p-dioxins polybromi-nated biphenyls and polychlorinated biphenyls in a two-stage system of mouse skin tumorigenesis: Potent anticarcinogenic effects; Ann. N.Y. Acad. Sci. 320 (1979) 405–414.

  • 217. Cohen G.M.; W.P. Bracken R.P. Iyer D.L. Berry and T.J. Slaga: Anticarcinogenic effects of 2378-tetrachlorodibenzo-p-dioxin on benzo[a]pyrene and 712-dimethylbenz[a]anthracene tumor initiation and its relationship to DNA binding; Cancer Res. 39 (1979) 4027–4033.

  • 218. DiGiovanni J.; D.L. Berry G.L. Gleason G.S. Kishore and T.J. Slaga: Time-dependent inhibition by 2378-tetrachlorodibenzo-p-dioxin of skin tumori-genesis with polycyclic hydrocarbons; Cancer Res. 40 (1980) 1580–1587.

Search
Journal information
Impact Factor


CiteScore 2018: 0.69

SCImago Journal Rank (SJR) 2018: 0.295
Source Normalized Impact per Paper (SNIP) 2018: 0.491

Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 375 227 3
PDF Downloads 168 112 8